Загрузка...
Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?
Intravesical onabotulinumtoxinA (BoNT-A) injections have been proposed to treat both overactive bladder (OAB) and interstitial cystitis/bladder pain syndrome (IC/BPS) in patients with refractory conditions. We compared adverse events (AEs) after BoNT-A treatment between IC/BPS and OAB in women. IC/B...
Сохранить в:
| Опубликовано в: : | Toxins (Basel) |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4810220/ https://ncbi.nlm.nih.gov/pubmed/26999201 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/toxins8030075 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|